Want full text access to this journal?
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
(no author information available yet)
No abstract text is available yet for this article.
March 19, 2019: European Heart Journal
#2
Frank Spillmann, Sophie Van Linthout, Gunther Schmidt, Oliver Klein, Nazha Hamdani, Thomas Mairinger, Florian Krackhardt, Bastian Maroski, Thomas Schlabs, Sajjad Soltani, Stefan Anker, Evgenij V Potapov, Daniel Burkhoff, Burkert Pieske, Carsten Tschöpe
AIMS: Haemodynamic load induces cardiac remodelling via mechano-transduction pathways, which can further trigger inflammatory responses. We hypothesized that particularly in an inflammatory disorder such as myocarditis, a therapeutic strategy is required which, in addition to providing adequate circulatory support, unloads the left ventricle, decreases cardiac wall stress, and mitigates inflammatory responses. METHODS AND RESULTS: Axial flow pumps such as the Impella systems comply with these requirements...
March 19, 2019: European Heart Journal
#3
Maria João Vieira, Nuno Craveiro, Miguel Alves, Vitor Martins
No abstract text is available yet for this article.
March 18, 2019: European Heart Journal
#4
Loïc Bière, Mouhamed-Ali Ba, Adrien Pascaud, Sophie Le Page
No abstract text is available yet for this article.
March 16, 2019: European Heart Journal
#5
Mathieu Kerneis, Johanne Silvain, Gilles Montalescot
No abstract text is available yet for this article.
March 15, 2019: European Heart Journal
#6
Richard A Brown, James C Moon, Paul T Telfer, Mohammed Y Khanji
No abstract text is available yet for this article.
March 15, 2019: European Heart Journal
#7
Peter A Noseworthy, Bernard J Gersh, David M Kent, Jonathan P Piccini, Douglas L Packer, Nilay D Shah, Xiaoxi Yao
AIMS: The Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial aimed to assess the impact of ablation on morbidity and mortality. This observational study was conducted in parallel to CABANA to assess trial generalizability. METHODS AND RESULTS: Using a large US administrative database, we identified 183 760 patients with atrial fibrillation (AF) treated with ablation or medical therapy (antiarrhythmic or rate control drugs) between 1 August 2009 and 30 April 2016 (CABANA enrolment period)...
March 15, 2019: European Heart Journal
#8
A John Camm
No abstract text is available yet for this article.
March 15, 2019: European Heart Journal
#9
Alberto Morales-Salinas, Richard Kones
No abstract text is available yet for this article.
March 14, 2019: European Heart Journal
#10
Scott T Chiesa, Marietta Charakida, Eve McLoughlin, Helen C Nguyen, Georgios Georgiopoulos, Laura Motran, Yesmino Elia, M Loredana Marcovecchio, David B Dunger, R Neil Dalton, Denis Daneman, Etienne Sochett, Farid H Mahmud, John E Deanfield
AIMS: High-density lipoprotein (HDL) function may be altered in patients with chronic disease, transforming the particle from a beneficial vasoprotective molecule to a noxious pro-inflammatory equivalent. Adolescents with Type 1 diabetes often have elevated HDL, but its vasoprotective properties and relationship to endothelial function have not been assessed. METHODS AND RESULTS: Seventy adolescents with Type 1 diabetes (age 10-17 years) and 30 age-matched healthy controls supplied urine samples for the measurement of early renal dysfunction (albumin:creatinine ratio; ACR), blood samples for the assessment of cardiovascular risk factors (lipid profiles, HDL functionality, glycaemic control, and inflammatory risk score), and had their conduit artery endothelial function tested using flow-mediated dilation (FMD)...
March 12, 2019: European Heart Journal
#11
Folkert W Asselbergs, Folkert J Meijboom
No abstract text is available yet for this article.
March 12, 2019: European Heart Journal
#12
(no author information available yet)
No abstract text is available yet for this article.
March 12, 2019: European Heart Journal
#13
Gonzalo Barge-Caballero, Paula López-Bargiela, Jorge Pombo-Otero, Patricia Pardo-Martínez
No abstract text is available yet for this article.
March 12, 2019: European Heart Journal
#14
Felix Grabher, Wolfgang Hamm, Steffen Massberg, Martin Orban
No abstract text is available yet for this article.
March 12, 2019: European Heart Journal
#15
Jos Lelieveld, Klaus Klingmüller, Andrea Pozzer, Ulrich Pöschl, Mohammed Fnais, Andreas Daiber, Thomas Münzel
AIMS: Ambient air pollution is a major health risk, leading to respiratory and cardiovascular mortality. A recent Global Exposure Mortality Model, based on an unmatched number of cohort studies in many countries, provides new hazard ratio functions, calling for re-evaluation of the disease burden. Accordingly, we estimated excess cardiovascular mortality attributed to air pollution in Europe. METHODS AND RESULTS: The new hazard ratio functions have been combined with ambient air pollution exposure data to estimate the impacts in Europe and the 28 countries of the European Union (EU-28)...
March 12, 2019: European Heart Journal
#16
Neil Herring, Nidi Tapoulal, Manish Kalla, Xi Ye, Lyudmyla Borysova, Regent Lee, Erica Dall'Armellina, Christopher Stanley, Raimondo Ascione, Chieh-Ju Lu, Adrian P Banning, Robin P Choudhury, Stefan Neubauer, Kim Dora, Rajesh K Kharbanda, Keith M Channon
AIMS: The co-transmitter neuropeptide-Y (NPY) is released during high sympathetic drive, including ST-elevation myocardial infarction (STEMI), and can be a potent vasoconstrictor. We hypothesized that myocardial NPY levels correlate with reperfusion and subsequent recovery following primary percutaneous coronary intervention (PPCI), and sought to determine if and how NPY constricts the coronary microvasculature. METHODS AND RESULTS: Peripheral venous NPY levels were significantly higher in patients with STEMI (n = 45) compared to acute coronary syndromes/stable angina ( n = 48) or with normal coronary arteries (NC, n = 16)...
March 11, 2019: European Heart Journal
#17
Devdas Thomas Inderbitzin, Christoph Krapf, Marc Buser, Carlos A Mestres
No abstract text is available yet for this article.
March 11, 2019: European Heart Journal
#18
Christophe Leclercq, Haran Burri, Antonio Curnis, Peter Paul Delnoy, Christopher A Rinaldi, Johannes Sperzel, Kwangdeok Lee, Leonardo Calò, Alfredo Vicentini, Joaquin Fernandez Concha, Bernard Thibault
AIMS: To assess the impact of MultiPoint™ Pacing (MPP)-programmed according to the physician's discretion-in non-responders to standard biventricular pacing after 6 months. METHODS AND RESULTS: The study enrolled 1921 patients receiving a quadripolar cardiac resynchronization therapy (CRT) system capable of MPP™ therapy. A core laboratory assessed echocardiography at baseline and 6 months and defined volumetric non-response to biventricular pacing as <15% reduction in left ventricular end-systolic volume (LVESV)...
March 11, 2019: European Heart Journal
#19
William A E Parker, Robert F Storey
No abstract text is available yet for this article.
March 11, 2019: European Heart Journal
#20
Audes D M Feitosa, Marco A Mota-Gomes, Wilson Nadruz
No abstract text is available yet for this article.
March 11, 2019: European Heart Journal
Fetching more papers... 
